Business Context and Reporting Period
This Form 8-K filing by Achieve Life Sciences, Inc. (ACHV) reports on the results of the Annual Meeting of Stockholders held on May 31, 2022. The company is incorporated in Delaware and its principal executive offices are located in Vancouver, BC, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The filing details the certified voting results for two matters submitted to security holders:
- Election of Directors: Eight nominees were elected to serve on the Board of Directors until the next annual meeting. All nominees received a majority of votes cast "For" their election, with Broker Non-Votes totaling 4,403,156 for each candidate.
- Ratification of Auditors: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified. The vote was overwhelmingly in favor (6,661,313 For vs. 18,435 Against).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors.
- Confirm the engagement of PricewaterhouseCoopers LLP for the 2022 fiscal year audit.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.